Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov 20:10:106.
doi: 10.1186/1745-6215-10-106.

Quality of reporting of randomized controlled trials in polycystic ovary syndrome

Anna Partsinevelou  1 , Elias Zintzaras
Affiliations

Quality of reporting of randomized controlled trials in polycystic ovary syndrome

Anna Partsinevelou et al. Trials. .

Abstract

Background: Inadequate reporting of randomized controlled trials (RCTs) is associated with biased estimates of treatment effects. The reporting quality of RCTs involving patients with polycystic ovary syndrome (PCOS) is unknown. The purpose of this study was to assess the reporting quality of RCTs involving patients with PCOS using a standardized tool based on the Consolidated Standards of Reporting Trials (CONSORT) statement.

Methods: We searched PubMed database for English-language RCTs involving patients with PCOS. Quality of reporting was assessed using a 24-item questionnaire based on the revised CONSORT checklist. Reporting was evaluated overall, and for pre- and post-CONSORT periods. RCTs on PCOS associated with fertility and non-fertility disturbances were also evaluated separately.

Results: Nine of the 24 items were reported in less than 50% of the studies, while a significant improvement (P < 0.05) was detected in 12 of 24 items (50%) over the two CONSORT periods. The RCTs on PCOS with reference to fertility seem to have adhered better to CONSORT statement than RCTs not associated to fertility.

Conclusion: There is empirical evidence of suboptimal reporting quality of RCTs in PCOS. Endorsement of the CONSORT statement may optimize the reporting quality and enhance the validity of research.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of citations through the retrieval and the screening process. RCT = randomized controlled trial; PCOS = Polycystic Ovary Syndrome.
See this image and copyright information in PMC

References

    1. Djulbegovic B, Loughran TP Jr, Hornung CA, Kloecker G, Efthimiadis EN, Hadley TJ, Englert J, Hoskins M, Goldsmith GH. The Quality of Medical Evidence in Hematology-Oncology. Am J Med. 1999;106(2):198–205. doi: 10.1016/S0002-9343(98)00391-X. - DOI - PubMed
    1. Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care. 1996;12(2):195–208. doi: 10.1017/S0266462300009570. - DOI - PubMed
    1. Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ. 1996;313(7057):570–1. - PMC - PubMed
    1. Ziogas DC, Zintzaras E. Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement. Ann Epidemiol. 2009;19(7):494–500. doi: 10.1016/j.annepidem.2009.03.018. - DOI - PubMed
    1. Papathanasiou AA, Zintzaras E. Assessing the Quality of Reporting of Observational Studies in Cancer. Ann Epidemiol. 2009. - PubMed

MeSH terms